Rowena Albanna - 04 Jun 2021 Form 4 Insider Report for Aditx Therapeutics, Inc. (ADTX)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Rowena Albanna
Issuer symbol
ADTX
Transactions as of
04 Jun 2021
Net transactions value
$0
Form type
4
Filing time
08 Jun 2021, 16:05:57 UTC
Previous filing
02 Jun 2021
Next filing
12 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADTX Common Stock Award $0 +75,000 +10% $0.000000 826,620 04 Jun 2021 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted common stock vests in three (3) successive equal annual installments, which began on March 31, 2021.
F2 Held beneficially by the husband of the Reporting Person.